Understanding ECG Rhythms: A Practical Guide for Clinicians

The electrocardiogram (ECG) is one of the most powerful and universally available diagnostic tools in clinical medicine. It records the electrical activity of the heart from multiple geometric perspectives simultaneously, producing a waveform that reflects atrial and ventricular depolarisation and repolarisation in real time.

A standard 12-lead ECG captures the heart's electrical activity from 12 different 'viewpoints' using 10 electrodes placed on the limbs and precordium. Inferior leads (II, III, aVF) view the inferior wall; lateral leads (I, aVL, V5–V6) view the lateral wall; and anterior leads (V1–V4) view the anterior wall — enabling precise anatomical localisation of pathology.

ECG interpretation is a core clinical skill across virtually every specialty — not just cardiology. Emergency physicians, anaesthetists, intensivists, and general practitioners encounter rhythms that require prompt recognition. The reassuring truth is that systematic reading can be learned methodically, and pattern recognition improves rapidly with deliberate practice.

The single most important habit in ECG interpretation is always using a structured sequence — evaluating every component in the same order, every time. This prevents the natural tendency to fixate on the most visually striking abnormality and miss concurrent findings.

The eight-step approach below covers all clinically essential parameters. Work through them in order on every ECG you encounter — without exception.

Normal sinus rhythm (NSR) is the reference rhythm: rate 60–100 bpm, upright P wave in lead II preceding every QRS, consistent PR interval 120–200 ms, narrow QRS <120 ms. Any deviation from these criteria constitutes an arrhythmia by definition.

Sinus tachycardia (rate >100 bpm) maintains all morphological features of NSR at an elevated rate. It is almost always secondary — driven by pain, fever, hypovolaemia, anaemia, anxiety, or drugs. Treating the underlying cause is the appropriate response; direct antiarrhythmic intervention is rarely indicated.

Atrial fibrillation (AF) — the most common sustained arrhythmia in clinical practice — presents with absent discrete P waves, a chaotically undulating fibrillatory baseline, and an irregularly irregular ventricular response. Rate may be slow, controlled, or rapid depending on AV node conduction and rate-limiting medications.

Ventricular tachycardia (VT) is a wide-complex tachycardia (QRS ≥120 ms) at rate typically >120 bpm. Distinguishing VT from SVT with aberrant conduction is clinically critical. The rule of thumb: when in doubt, treat as VT. AV dissociation, fusion beats, and capture beats all strongly support VT.

Ventricular fibrillation (VF) produces a chaotic, disorganised tracing with no identifiable waveforms — only undulating signals of variable amplitude and frequency. It produces no effective cardiac output and is immediately life-threatening, requiring instant defibrillation without delay for rhythm confirmation.

A structured tachycardia decision pathway begins with haemodynamic assessment, not rhythm diagnosis. If the patient is unstable (hypotension, impaired consciousness, chest pain, acute pulmonary oedema) → immediate synchronised DC cardioversion regardless of rhythm type. Stability assessment precedes rhythm analysis in every resuscitation algorithm.

For stable narrow-complex tachycardia, the sequence is: vagal manoeuvres first → IV adenosine if unsuccessful → rhythm-specific antiarrhythmic therapy once the diagnosis is confirmed. Adenosine's ultra-short half-life (~10 seconds) makes it simultaneously diagnostic and therapeutic — its transient AV block unmasks atrial activity that confirms AF, flutter, or re-entrant SVT.

For stable wide-complex tachycardia, assume VT as the default. IV amiodarone or procainamide are first-line pharmacological choices. Never use verapamil or diltiazem in wide-complex tachycardia of uncertain origin — in VT, calcium-channel blockade can precipitate haemodynamic collapse.

The bradycardia pathway begins with atropine (500 mcg IV bolus, up to 3 mg total) for symptomatic sinus bradycardia or AV block. If atropine is ineffective — or the block is high-degree (Mobitz II or third-degree) — transcutaneous pacing bridges to transvenous pacing or definitive permanent pacing.

Over-relying on automated computer interpretation is one of the most prevalent errors. Algorithms perform adequately for rate and basic rhythm analysis but have documented poor sensitivity for subtle STEMI equivalents, intermittent blocks, and complex arrhythmias. Treat the automated report as a starting point — never as a substitute for independent tracing review.

Failing to compare with a prior ECG is a missed opportunity that leads to frequent misdiagnosis. A new bundle branch block, Q wave, or ST change that appears chronic may be acutely new — a distinction that changes management entirely. Always request previous recordings whenever available.

Missing atrial flutter at 2:1 conduction is a classic pitfall. Flutter at 300 bpm conducted 2:1 produces a regular narrow-complex tachycardia at 150 bpm — superficially resembling sinus tachycardia. Practical rule: any regular tachycardia at exactly 150 bpm should be assumed to be flutter with 2:1 block until proven otherwise.

Ignoring lead placement artefact — particularly limb lead reversal — produces dramatic apparent axis changes, pseudo-ST changes, and inverted P waves. If the P wave is inverted in lead I with positive aVR, suspect left-right arm reversal before attributing findings to pathology.